Please ship all orders and specimens to:

HNL Genomics (CTGT)
6575 Snowdrift Road, Suite 106
Allentown, PA 18106 USA
Phone: (484) 244-2900

Before shipping, please be sure to review ALL instructions below that apply to your specimen(s).

All Shipments
  • Shipment via express carrier (such as FedEx, UPS or DHL) is recommended.  In addition to rapid delivery, express carriers provide package tracking.

  • Please do NOT send specimens for weekend or U.S. holiday delivery. HNL Genomics (CTGT) accepts shipments only on regular business days.

  • All specimens should be appropriately packaged to avoid crushing, breaking or leaking and should be sent in the commercial packaging available from the selected express carrier.

  • Requisition Forms MUST accompany all specimens.  If specimens for more than one individual are being shipped together, please include a requisition form for each specimen.

  • All specimens and Requisition Forms must be clearly marked with at least two patient identifiers (for example, patient name and date of birth).

  • A packing slip detailing the contents of your shipment should be included with each package sent. Please complete the Shipment Packing Slip and include in the package.

Shipments from Outside of the United States
  • Shipment via express carrier is highly recommended for all shipments originating outside of the United States. In addition to rapid delivery, express carriers provide package tracking and encounter fewer issues with customs.

  • Please follow all applicable regulations and guidelines for shipping of specimens for medical testing.

  • Genomic DNA should be submitted for all overseas shipments (outside of the United States, Canada or Mexico).  Blood or cultured cells may not survive transit and have a greater probability of being held either in the country of origin or in U.S. customs.


NOTE: Shipment of specimens to HNL Genomics (CTGT) is the sole responsibility of the sender.  Shipping charges billed to HNL Genomics (CTGT) will be automatically rebilled to the sender.

Please include a packing slip with your shipment. Download the Shipment Packing Slip.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.


October 28, 2022

Non-Hodgkin Lymphoma FISH Panel Now Available

B-cell lymphoma is a large group of heterogenous disorders and comprises a majority of non-Hodgkin lymphomas.
Read More
October 20, 2022

Genetic testing for Familial Transthyretin Amyloidosis (TTR) NOW AVAILABLE In-House

Hereditary amyloidosis is a life-threatening disorder that can lead to peripheral neuropathy and heart failure.
Read More
August 08, 2022

Familial hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More